Contrast for the kidney is particularly useful in the examination of anatomic variations, complex cystic lesions, suspected cystic carcinoma, renal trauma, and residual tumor after RF and other ablative techniques. During follow-up, contrast-enhanced imaging may be used for detecting the presence of vascularity after performing an ablative treatment, or for example, for monitoring kidney transplants.
Learn about the Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) at EFSUMB.org (European Federation of Societies for Ultrasound in Medicine and Biology).
Contrast can be used on the prostate. The Prostate Triplane 8818 and Endocavity Biplane 8848 transducers are ideal for measuring vascularity after ablation to verify success.
Download a brochure about prostate contrast ultrasound.
Contact us for more information about the use of Contrast Enhanced Ultrasound.
* Contrast Enhanced Ultrasound (CEUS) has not been market cleared by the FDA for use in the USA.